| View |
|
DR-XY36508
|
Levofloxacin (as Hemihydrate)
|
Levoflox
|
5mg/mL
|
Solution For Iv Infusion
|
Antibacterial (Flouroquinolone)
|
LBS Laboraotry LP
|
Thailand
|
Renewal
|
15 May 2024
|
14 August 2029
|
| View |
|
DR-XY36539
|
Amlodipine (as besilate)
|
Eodipine 10
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
Renewal
|
19 May 2024
|
19 August 2029
|
| View |
|
DR-XY36548
|
Tamsulosin Hydrochloride
|
Pimax
|
400 mcg
|
Enteric-Coated Tablet
|
Alpha - 1 Adrenoceptor Blocker ( for Bening Prostic Hyperplasia )
|
Unicare Remedies Pvt. Ltd.
|
India
|
Renewal
|
27 May 2024
|
25 August 2029
|
| View |
|
DR-XY36551
|
Cefuroxime (as Sodium)
|
Zefuxim
|
250mg
|
Powder for Injection
|
ANTIBACTERIAL
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Automatic Renewal
|
05 July 2023
|
29 August 2028
|
| View |
|
DR-XY36564
|
Celecoxib
|
Celcoxx
|
400mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Getz Pharma (Private) Limited
|
Pakistan
|
Renewal
|
29 January 2024
|
26 August 2029
|
| View |
|
DR-XY36568
|
Ofloxacin
|
Ocin
|
3mg/ mL (0.3% w/v)
|
Eye Drops Solution
|
Antibacterial Quinolone
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
03 August 2021
|
27 August 2026
|
| View |
|
DR-XY36586
|
Cetirizine Dihydrochloride + Phenylephrine Hydrochloride
|
Alnix Plus
|
5 mg/10 mg
|
Film-Coated Tablet
|
Antihistamine/Nasal Decongestant
|
Amherst Laboratories, Inc.
|
Philppines
|
Renewal
|
09 August 2022
|
19 September 2027
|
| View |
|
DR-XY36604
|
Isosorbide-5-Mononitrate
|
Montra
|
60 mg
|
Sustained-Release Capsule
|
Anti-angina
|
Inventia Healthcare Pvt. Ltd.
|
India
|
Renewal
|
25 July 2024
|
10 September 2029
|
| View |
|
DR-XY36606
|
Isosorbide-5-Mononitrate
|
Montra
|
30 mg
|
Sustained-Release Capsule
|
Anti-angina
|
Inventia Healthcare Pvt. Ltd.
|
India
|
Renewal
|
29 June 2024
|
10 September 2029
|
| View |
|
DR-XY36609
|
Risperidone
|
Residon
|
2 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Pharmathen S.A
|
Greece
|
Renewal
|
31 August 2024
|
03 September 2029
|
| View |
|
DR-XY36610
|
Risperidone
|
Residon
|
4mg
|
Film Coated Tablet
|
Antipsychotic
|
Pharmathen S.A
|
Greece
|
Renewal
|
31 August 2024
|
03 September 2029
|
| View |
|
DR-XY36625
|
Citicoline
|
Cikolin
|
250 mg/mL (500mg/2mL)
|
Solution For Injection
|
CNS Stimulant
|
Huons Co., Ltd.
|
Korea
|
Renewal
|
29 September 2024
|
08 September 2029
|
| View |
DR-XY36632_PI_01.pdf
|
DR-XY36632
|
Levetiracetam
|
Keppra
|
500 mg/5 mL
|
Concentrate For Solution For IV Infusion
|
Antiepileptic
|
Patheon Italia S.p.A.
|
Italy
|
Renewal
|
01 July 2024
|
10 September 2029
|
| View |
|
DR-XY36634
|
Chlorhexidine Gluconate
|
None
|
1.2mg/ mL (0.12% w/v)
|
Oral Rinse Solution
|
Antiseptic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
30 January 2022
|
11 September 2026
|
| View |
|
DR-XY36636
|
Docusate Sodium
|
Otowax
|
5 mg/mL (0.5%)
|
Ear Drops
|
Ceruminolytic
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
08 January 2024
|
11 September 2029
|
| View |
|
DR-XY36639
|
Paracetamol + Propyphenazone + Caffeine
|
Saridon Triple Action
|
250mg/ 150mg/ 50mg
|
Tablet
|
Analgesic/Antipyretic
|
PT. Bayer Indonesia
|
Indonesia
|
Renewal
|
27 May 2024
|
11 September 2029
|
| View |
|
DR-XY36653
|
Timolol (As Maleate)
|
Optamol
|
2.5 mg/Ml (0.25%w/v)
|
Ophthalmic Solution (Eye Drops)
|
Antiglaucoma / Beta-Adrenergic Blocking Agent
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
28 September 2024
|
16 September 2029
|
| View |
|
DR-XY36667
|
Ofloxacin
|
Flox
|
2 mg/ mL (200 mg/ 100 mL)
|
Solution for IV Infusion
|
Antibacterial
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
29 June 2024
|
17 September 2029
|
| View |
|
DR-XY36670
|
0.9% Sodium Chloride
|
Salnor
|
9mG/Ml( 0.9% w/v)
|
Solution For Iv Infusion
|
Electrolyte
|
Otsuka Pharmaceutical India Private Limited
|
India
|
Renewal
|
20 October 2024
|
17 September 2029
|
| View |
|
DR-XY36676
|
Cefepime (as Hydrochloride)
|
Zepime
|
1g
|
Powder For Injection (IM/IV)
|
Antibacterial
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
08 July 2024
|
22 September 2029
|